NUTRIDA
NUTRIDA, licence 80039563: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- HELSURE
- Licence holder
- Nutrida Canada Corp.
- NPN or DIN-HM
- 80039563
- Status
- Active licence
- Licence date
- 5 February 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium bifidum Source : BB-02 | 1.0 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 1.0 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Maltodextrine, Poudre de fruits en gros, Poly(dextrose), Acide L-malique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 13.0 Année(s) | 40.0 Milliards d'UFC | 1.0 Jour(s) |
| Enfants | minimum: 3.0 Année(s) ; maximum: 12.0 Année(s) | minimum: 6.0 Milliards d'UFC ; maximum: 10.0 Milliards d'UFC | 1.0 Jour(s) |
Uses authorised in Canada
Provides live microorganisms that temporarily modify gut flora (Elli et al. 2006; FAO/WHO 2006; Bezkorovainy 2001; Conway 1987). Probiotics that temporarily modify gut flora (Elli et al. 2006; FAO/WHO 2006; Bezkorovainy 2001; Conway 1987). Source of probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product (APhA 2006; Cukovic-Cavka et al. 2006; Ledoux et al. 2006).
- Précautions et mises en garde
If you have nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use (APhA 2006; WHO 2005; CPhA 2002). If symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner (APA 2006; WHO 2005).
Source
Official Health Canada record, licence 80039563
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.